A meta-analysis of neoadjuvant chemotherapy combined with trastuzumab for HER2-positive breast cancers

Nan fang yi ke da xue xue bao = Journal of Southern Medical University

Volumn 29, Issue 5, 2009, Pages 943-945

  Liao, Ning ^a   Zhang, Guo chun ^a   Li, Xue rui ^a   Yao, Meng ^a   Wang, Kun ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HER2 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; TRASTUZUMAB;

ADJUVANT THERAPY; ARTICLE; BREAST TUMOR; FEMALE; GENETICS; HUMAN; META ANALYSIS; METABOLISM; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HUMANS; NEOADJUVANT THERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTOR, ERBB-2;

EID: 77951905681     PISSN: 16734254     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)